The anti-leukemic and lipid lowering effects of imatinib are not hindered by statins in CML: a retrospective clinical study andin vitroassessment of lipid-genes transcription-Reference-Cited by-同舟云学术

The anti-leukemic and lipid lowering effects of imatinib are not hindered by statins in CML: a retrospective clinical study andin vitroassessment of lipid-genes transcription

Published:2016-09-21 Issue:5 Volume:58 Page:1172-1177
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ellis Martin¹²,Krashin Eilon³,Hamburger-Avnery Orly¹,Gan Sarah¹²,Elis Avishai²⁴,Ashur-Fabian Osnat¹⁵

Affiliation:

1. Translational Hemato-Oncology Laboratory, Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel;

2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;

3. Department of Internal Medicine A, Meir Medical Center, Kfar-Saba, Israel;

4. Department of Internal Medicine C, Beilinson Campus, Rabin Medical Center, Petah Tikva, Israel;

5. The Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2016.1228928

Reference32 articles.

1. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review

2. Pushing the limits of targeted therapy in chronic myeloid leukaemia

3. Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015

4. Survival benefit with imatinib mesylate versus interferon-α–based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia

5. Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations in cellular metabolisms after TKI therapy for Philadelphia chromosome-positive leukemia in children: A review;Frontiers in Oncology;2022-12-06

2. Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues;Frontiers in Cardiovascular Medicine;2022-08-09

3. Alterations in cellular metabolisms after Imatinib therapy: a review;Medical Oncology;2022-05-16

4. Effects of imatinib on glycemic and lipid profiles: a retrospective cohort study;Leukemia & Lymphoma;2022-04-27